SEARCH

SEARCH BY CITATION

References

  • Adams SV, DeFelice LJ (2003). Ionic currents in the human serotonin transporter reveal inconsistencies in the alternating access hypothesis. Biophys J 85: 15481559.
  • Baldwin RL (2013). The new view of hydrophobic free energy. FEBS Lett 587: 10621066.
  • Baumann MH, Ayestas MA, Partilla JS, Sink JR, Shulgin AT, Daley PF et al. (2012). The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology 37: 11921203.
  • Boehm S (1999). ATP stimulates sympathetic transmitter release via presynaptic P2X purinoceptors. J Neurosci 19: 737746.
  • Bulling S, Schicker K, Zhang Y-W, Steinkellner T, Stockner T, Gruber C et al. (2012). The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transporters. J Biol Chem 287: 1852418534.
  • Erreger K, Grewer C, Javitch JA, Galli A (2008). Currents in response to rapid concentration jumps of amphetamine uncover novel aspects of human dopamine transporter function. J Neurosci 28: 976989.
  • Fischer JF, Cho AK (1979). Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J Pharmacol Exp Ther 208: 203209.
  • Fog JU, Khoshbouei H, Holy M, Owens WA, Vaegter CB, Sen N et al. (2006). Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron 51: 417429.
  • Gnegy ME (2003). The effect of phosphorylation on amphetamine-mediated outward transport. Eur J Pharmacol 479: 8391.
  • Gobbi M, Funicello M, Gerstbrein K, Holy M, Moya PR, Sotomayor R et al. (2008). N,N-dimethyl-thioamphetamine and methyl-thioamphetamine, two non-neurotoxic substrates of 5-HT transporters, have scant in vitro efficacy for the induction of transporter-mediated 5-HT release and currents. J Neurochem 105: 17701780.
  • Hilber B, Scholze P, Dorostkar MM, Sandtner W, Holy M, Boehm S et al. (2005). Serotonin-transporter mediated efflux: a pharmacological analysis of amphetamines and non-amphetamines. Neuropharmacology 49: 811819.
  • Hille B (1977). The pH-dependent rate of action of local anesthetics on the node of Ranvier. J Gen Physiol 69: 475496.
  • Kahlig KM, Binda F, Khoshbouei H, Blakely RD, McMahon DG, Javitch J et al. (2005). Amphetamine induces dopamine efflux through a dopamine transporter channel. Proc Natl Acad Sci U S A 102: 34953500.
  • Kristensen AS, Andersen J, Jørgensen TN, Sørensen L, Eriksen J, Loland CJ et al. (2011). SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacol Rev 63: 585640.
  • Laeuger P (1991). Electrogenic Ion Pumps. Sinauer Associates Inc: Sunderland, MA.
  • Lin F, Lester HA, Mager S (1996). Single-channel currents produced by the serotonin transporter and analysis of a mutation affecting ion permeation. Biophys J 71: 31263135.
  • Mager S, Min C, Henry DJ, Chavkin C, Hoffman BJ, Davidson N et al. (1994). Conducting states of a mammalian serotonin transporter. Neuron 12: 845859.
  • Nelson PJ, Rudnick G (1979). Coupling between platelet 5-hydroxytryptamine and potassium transport. J Biol Chem 254: 1008410089.
  • Petersen CI, DeFelice LJ (1999). Ionic interactions in the Drosophila serotonin transporter identify it as a serotonin channel. Nat Neurosci 2: 605610.
  • Quick MW (2003). Regulating the conducting states of a mammalian serotonin transporter. Neuron 40: 537549.
  • Reynolds JA, Gilbert DB, Tanford C (1974). Empirical correlation between hydrophobic free energy and aqueous cavity surface area. Proc Natl Acad Sci U S A 71: 29252927.
  • Rodriguez-Menchaca AA, Solis E, Cameron K, De Felice LJ (2012). S(+)amphetamine induces a persistent leak in the human dopamine transporter: molecular stent hypothesis. Br J Pharmacol 165: 27492757.
  • Rothman RB, Baumann MH (2003). Monoamine transporters and psychostimulant drugs. Eur J Pharmacol 479: 2340.
  • Rudnick G, Nelson PJ (1978). Platelet 5-hydroxytryptamine transport, an electroneutral mechanism coupled to potassium. Biochemistry 17: 47394742.
  • Rudnick G, Wall SC (1992). p-Chloroamphetamine induces serotonin release through serotonin transporters. Biochemistry 31: 67106718.
  • Schicker K, Uzelac Z, Gesmonde J, Bulling S, Stockner T, Freissmuth M et al. (2011). A unifying concept of serotonin transporter associated currents. J Biol Chem 287: 438445.
  • Schmidt H, Jirstrand M (2006). Systems Biology Toolbox for MATLAB: a computational platform for research in systems biology. Bioinformatics 22: 514515.
  • Seidel S, Singer EA, Just H, Farhan H, Scholze P, Kudlacek O et al. (2005). Amphetamines take two to tango: an oligomer-based counter-transport model of neurotransmitter transport explores the amphetamine action. Mol Pharmacol 67: 140151.
  • Sitte HH, Freissmuth M (2010). The reverse operation of Na(+)/Cl(-)-coupled neurotransmitter transporters-why amphetamines take two to tango. J Neurochem 112: 340355.
  • Sitte HH, Huck S, Reither H, Boehm S, Singer EA, Pifl C (1998). Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter. J Neurochem 71: 12891297.
  • Sitte HH, Hiptmair B, Zwach J, Pifl C, Singer EA, Scholze P (2001). Quantitative analysis of inward and outward transport rates in cells stably expressing the cloned human serotonin transporter: inconsistencies with the hypothesis of facilitated exchange diffusion. Mol Pharmacol 59: 11291137.
  • Sonders MS, Zhu SJ, Zahniser NR, Kavanaugh MP, Amara SG (1997). Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants. J Neurosci 17: 960974.
  • Steinkellner T, Yang J-W, Montgomery TR, Chen W-Q, Winkler M-T, Sucic S et al. (2012). Ca(2+)/calmodulin-dependent protein kinase IIα (αCaMKII) controls the activity of the dopamine transporter: implications for Angelman syndrome. J Biol Chem 287: 2962729635.
  • Sucic S, Dallinger S, Zdrazil B, Weissensteiner R, Jørgensen TN, Holy M et al. (2010). The N terminus of monoamine transporters is a lever required for the action of amphetamines. J Biol Chem 285: 1092410938.
  • Sulzer D, Maidment NT, Rayport S (1993). Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J Neurochem 60: 527535.
  • Sulzer D, Chen TK, Lau YY, Kristensen H, Rayport S, Ewing A (1995). Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J Neurosci 15: 41024108.